TipRanks
Go Ultimate55% OFF

Kimberly Clark (0JQZ) AI Stock Analysis

GB:0JQZ

Kimberly Clark

(LSE:0JQZ)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Profitability and Revenue ReboundConsistent margins and a strong TTM revenue rebound indicate the core hygiene portfolio retains earnings power while demand improves. This gives Kimberly-Clark capacity to fund brand investment, innovation and productivity initiatives, supporting resilience over the next several quarters.
Negative Factors
Elevated LeverageAlthough leverage has improved from prior years, debt remains high relative to equity and limits financial flexibility. A heavily leveraged balance sheet can constrain investment choices, increase sensitivity to weaker earnings or cash flow, and complicate funding for strategic initiatives.

Kimberly Clark (0JQZ) vs. iShares MSCI United Kingdom ETF (EWC)

-5%0%5%10%15%20%25%30%GB:0JQZ+14.93%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$35.90B
Dividend Yield
4.66%
Average Volume (3M)
3,224
Price to Earnings (P/E)
18.4
Beta (1Y)
0.42
Revenue Growth
-12.19%
EPS Growth
-19.22%
Country
UK
Employees
36,000
Sector
Consumer Defensive
Sector Strength
62
Industry
Household & Personal Products

Kimberly Clark Business Overview & Revenue Model

Company Description

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable...

Kimberly Clark Earnings Call Summary

Earnings Call Date:Aug 03, 2026(Q2-2026)|% Change Since:1.56%|Next Earnings Date:Nov 04, 2026
Earnings Call SentimentNeutral

The call balanced operational and strategic strengths against several meaningful near-term headwinds. Positives included sustained volume-plus-mix momentum (10 consecutive quarters), industry-leading productivity (6.4%), a $45M tariff refund that boosted Q2 operating profit and EPS, progress on Arbex and Kenvue integration, and a compelling innovation roadmap highlighted by an alternative natural fiber program. Offsetting those strengths were discrete and material challenges: a China diaper disruption (noted as significant and causing quarterly basis-point impacts), retailer destocking and an LA distribution-center fire that pressured North America shipments, a moderating category growth backdrop, elevated input-cost headwinds (~$150M in H2), and increased promotional/competitive intensity. Management expects to mitigate inflationary impacts and remains confident in long-term prospects, but near-term visibility (including 2027 cadence) is limited.

Positive Updates

Sustained Volume + Mix Momentum
Delivered 10th consecutive quarter of positive volume plus mix performance; sustained positive trailing performance with volume/mix-led growth in 8 of the last 10 quarters in North America and trailing 12-month category growth ~2%.

Negative Updates

China Diaper Disruption
Significant social-media-driven disruption in China diapers (largest incident they've faced), which produced a meaningful sellout/consumption impact: roughly a 50 basis point headwind in Q2; management referenced uncertainty in recovery and incorporated China weakness into outlook (guidance previously assumed ~100 bps for the year; management later discussed ~200 bps of second-half impact distributed across Q3/Q4).

Company Guidance

Kimberly‑Clark updated its 2026 outlook to reflect a $45 million U.S./Canada tariff refund and about $150 million of gross input‑cost headwinds in H2 (the company had previously cited $150–$170M if oil were ~$100/bbl), which management says will be largely offset by mitigating actions and productivity so that pricing net of cost inflation is roughly neutral for the full year; Q2 organic sales ran ~100 basis points below expectations, driven in part by a ~50‑bp China diaper sell‑out impact in Q2 (management had contemplated ~100 bps for the year) and North America retailer destocking, with North America shipments lagging consumption by ~170 bps in Q2 (shipments −1.4% vs consumption +0.3%) and ~200 bps for the first half. Despite the noise, the company delivered its 10th consecutive quarter of positive volume plus mix, industry‑leading gross productivity of 6.4%, adjusted operating profit and EPS that beat expectations (helped by the $45M refund), weighted‑share performance broadly stable, 1H pricing down ~50 bps overall but planned low‑single‑digit pricing actions in North America in H2, and reiterated confidence in the Kenvue transaction ($1.9B synergy target with integration planning running ahead; further 2027 detail to be provided as close approaches).

Kimberly Clark Risk Analysis

Kimberly Clark disclosed 26 risk factors in its most recent earnings report. Kimberly Clark reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Kimberly Clark Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

GB:0JQZ against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
CHDCHD78Outperform$25.44B32.8918.21%1.14%1.70%2.07%
PGPG72Outperform$374.48B23.9429.55%2.68%3.52%-3.74%
CLCL67Neutral$75.96B37.021135.82%2.21%5.91%-28.30%
ULUL64Neutral$140.47B13.7058.26%3.41%-17.45%8.84%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
CLXCLX54Neutral$10.64B18.26-1893.55%5.66%-5.41%-26.46%

* Consumer Defensive Sector Average

Performance Comparison

-20%0%20%GB:0JQZCHDCLXCLPGULDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:0JQZ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0JQZKimberly Clark109.4011.4811.72%
CHDChurch & Dwight Company107.2322.0525.89%
CLXClorox Company88.00-15.86-15.27%
CLColgate-palmolive Company95.2922.0730.14%
PGProcter & Gamble Company161.5717.7212.32%
ULUnilever plc65.262.433.87%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.